Amy Schulman

Amy Schulman

Chairman bei ALNYLAM PHARMACEUTICALS, INC.

Vermögen: 30 814 $ am 31.03.2024

63 Jahre
Health Technology
Commercial Services
Health Services

Profil

Amy L.
Schulman
is the founder of Lyndra Therapeutics, Inc. (founded in 2015) and LS Polaris Innovation Fund (founded in 2017).
She is also the founder of Suono Bio, Inc. Ms. Schulman's current job(s) include being the Chairman of SQZ Biotechnologies Co. since 2015 and the Chairman of Alnylam Pharmaceuticals, Inc. since 2014.
She is also a Director at Pet Products, Inc., Wesleyan University, The Mount Sinai Hospital, Equal Justice Works, Action Against Hunger-USA, Kallyope, Inc., Cardurion Pharmaceuticals LLC, Thirty Madison, Inc., Glympse Bio, Inc., Dewpoint Therapeutics, Inc., ByHeart, Inc., Candesant Biomedical, Inc., Volastra Therapeutics, Inc., Amagma, Inc., Vico Therapeutics BV, Hudson Executive Investment Corp.
II, Larkspur Biosciences, Inc., and a Managing Partner at Polaris Growth Management LLC.
Ms. Schulman's former job(s) include being the Chief Executive Officer of Eagle Biologics, Inc. from 2014 to 2016, the Executive Chairman & Chief Executive Officer of Olivo Laboratories LLC, an Independent Director at Ironwood Pharmaceuticals, Inc. from 2017 to 2019, a Director at DNIB Unwind, Inc. from 2014 to 2016, the Lead Independent Director at Arsanis, Inc. from 2015 to 2019, a Director at Zoetis, Inc. from 2012 to 2013, a Director at Whitehead Institute for Biomedical Research, a Director at Brooklyn Academy of Music, an Independent Director at Blue Buffalo Pet Products, Inc., a Director at Quentis Therapeutics, Inc., an Independent Director at Cyclerion Therapeutics, Inc. from 2019 to 2020, an Independent Director at Hudson Executive Investment Corp., the Executive Vice President & General Counsel at Wyeth LLC, the President-Vaccines, Oncology & Consumer Healthcare at Pfizer Inc. from 2013 to 2014, a Member at The Brookings Institution, and a Partner at DLA Piper LLP (United States).
Ms. Schulman's education includes an undergraduate degree from Wesleyan University and a graduate degree from Yale Law School (conferred in 1989).

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.01.2024 136 ( 0,00% ) 20 325 $ 31.03.2024
31.12.2023 218 514 ( 0,74% ) 10 489 $ 31.03.2024
02.02.2024 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Amy Schulman

UnternehmenPositionBeginn
ALNYLAM PHARMACEUTICALS, INC. Chairman 05.01.2023
SQZ BIOTECHNOLOGIES COMPANY Chairman 01.07.2015
HUDSON EXECUTIVE INVESTMENT CORP. II Director/Board Member 25.01.2021
FRACTYL HEALTH, INC. Director/Board Member 01.09.2018
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Alle aktiven Positionen von Amy Schulman

Ehemalige bekannte Positionen von Amy Schulman

UnternehmenPositionEnde
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Amy Schulman im Detail an

Ausbildung von Amy Schulman

Wesleyan University Undergraduate Degree
Yale Law School Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Amy Schulman im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

44

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen7
PFIZER, INC.

Health Technology

IRONWOOD PHARMACEUTICALS, INC.

Health Technology

SQZ BIOTECHNOLOGIES COMPANY

Health Technology

ALNYLAM PHARMACEUTICALS, INC.

Health Technology

ZOETIS INC.

Health Technology

FRACTYL HEALTH, INC.

Health Technology

CYCLERION THERAPEUTICS, INC.

Health Technology

Private Unternehmen35

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Producer Manufacturing

Commercial Services

Commercial Services

Health Services

Consumer Services

Commercial Services

Equal Justice Works

Commercial Services

Consumer Services

Consumer Non-Durables

Health Technology

Consumer Non-Durables

Health Services

Technology Services

Health Services

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Finance

Health Services

Health Technology

Finance

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Amy Schulman